Author

Yue Cao

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Virological Events During Immune Checkpoint Inhibitor Therapy: A Multi-Source Evaluation

Background/Objectives: Virological findings during immune checkpoint inhibitor (ICI) therapy may represent viral loss of control, pre-existing infection, tumour biomarkers, or infection after immune-related adverse event (irAE)-directed immunosuppression. Distinguishing these possibilities is important for treatment an...

Yue Cao, Zeng-Hui Zhang, Yan Liang et al. · Pharmaceuticals · 0 citations

Open access Aug 2026

Serum COPA for the diagnosis and immunotherapeutic monitoring of hepatocellular carcinoma: a retrospective study

Background and Purpose Investigating the assessment of innovative serum indicators with elevated sensitivity and specificity is crucial for enhancing the early diagnosis and prognosis of HCC (Hepatocellular carcinoma). This study aimed to evaluate the efficacy of COPA (Coatomer Subunit Alpha) in diagnosing hepatocellul...

R. Cui, Yue Cao, Li Ren et al. · Frontiers in Pharmacology · 0 citations

Open access Sep 2026

GDF15-integrated blood biomarker panel for risk stratification of digestive malignancies: a multicenter retrospective study

Background Digestive malignancies remain a major cause of cancer-related mortality worldwide. Current diagnostic approaches are often limited by invasiveness, cost, and accessibility. We aimed to develop a blood-based risk stratification model for identifying individuals at increased risk of digestive malignancies. Met...

R. Cui, Yue Cao, Yue-Guo Li · Frontiers in Pharmacology · 0 citations